Tim Talbot

Memorial Sloan-Kettering Cancer CenterNew York, New York - 10065 (646-888-0023) |
- CLINICAL TRIALS 1
- CONDITIONS3
- INTERVENTIONS1
- SINCE2009

Efficacy and Safety of Panobinostat (LBH5789) in Patients With Refractory de Novo or Secondary Acute Myelogenous Leukemia (AML)
August 2009 - July 2011
Leukemia
Leukemia, Myeloid, Acute
Leukemia, Myeloid
Panobinostat/Lbh589



